TORONTO — Canadian and U.S. cannabis companies are facing a spike in already high costs of insurance to protect top executives from personal liability, following a slew of lawsuits by disgruntled investors alleging fraud and misinformation, with more such action expected.

Some of the biggest cannabis companies, including Medmen Enterprises, Canopy Growth, CannTrust Holdings, Aphria Inc and Columbia Care, have faced shareholder litigation, accusing leaders of false claims, failing to act in the interest of all shareholders and attempts to defraud investors.

View the Full Article Below:

 

Looking for our 2022 State of the Industry Report?

Are you in the cannabis industry? Our 2022 State of the Industry report will give you key insights into how to proceed in your business and how to navigate the industry in general this year.

You will recieve the report straight to your inbox once published!